Interesting…
I’m not sure why he was proposing that Fin permanently blocks AR’s? By what mechanism? I guess in order to really know if what you posted abolishes any doubts about how he is saying fin permanently blocks AR’s we would need to know what his proposed mechanism is of how Fin is doing this ? Either way we have seen no evidence that Fin does this.
Initially though he was talking about the enzyme and if Fin works as a reversible or nonreversible inhibitor of the enzyme. And I think he has a point about this. I do remember reading Fin is a Nonreversible inhibitor years back. Now (like he was saying) those sources are just gone or at least harder to find…
Instead now everything says Fin is a competitive inhibitor which suggests it’s reversible. So I find this suspicious as well. Also if Fin is a competitor inhibitor it may still be acting in a nonreversible way. I think what it’s doing to the substrate should be looked at in more detail. Here:
http://cbm.msoe.edu/crest/posters/2015CUWSP/15finasteride.html](http://cbm.msoe.edu/crest/posters/2015CUWSP/15finasteride.html)
“Mechanism-based inactivation of 5α-reductase type 2 by finasteride showing a hydride reaction occurring between finasteride and NADPH that results in a covalent bond between finasteride and the cofactor. [R = -C(=O)-NH2; PADPR = 2’-phosphoadenosine-5’’-diphosphoribose; A-H = TYR58.7]”
We should look into this in more detail? What does this mean exactly? Covalent bond is permanent correct?
Also this:
“Although it is accepted as an alternate substrate and is ultimately reduced to dihydrofinasteride, this proceeds through an enzyme-bound NADP−dihydrofinasteride adduct”
“the binding of NADPHto the enzyme followed by the substrate”
Maybe you guys should try to get tested to see if you have still have dihydrofinasteride in your blood. I did not take fin so this is not an avenue for me to take.